April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

By Vanderbilt Health News

March 3, 2012

Reversing lipid woes in cystic fibrosis

Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.

By Leigh MacMillan

February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

By Vanderbilt Health News

December 15, 2011

Young stem cells counter kidney aging

Young bone marrow cells alleviate aging-related kidney changes in mice.

By Vanderbilt Health News

November 11, 2011

Balancing act in the gut

Vanderbilt researchers have identified an antigen important to balancing the immune response to bacteria in the gut.

By Leigh MacMillan

February 15, 2008

Immune system protein starves ‘staph’ bacteria

One of the ways we defend ourselves against bacterial foes is to “hide” their food, particularly the metals they crave. A multi-disciplinary team led by Vanderbilt University investigators has now discovered that a protein inside certain immune system cells blocks the growth of “staph” bacteria by sopping up manganese and zinc.